Abbott Laboratories

ABT - Abbott Laboratories • Financials

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
40,109
9,721
-
14%
3.3
38,603
15%
6,320
0.65
6,617
-2,202
-7,091
4,415
-1,227
-3,556
62%
1.85%
41,950
10,043
-
32%
7.7
47,664
28%
4,658
0.46
7,885
-2,207
-5,404
5,678
-1,295
-3,836
29%
1.95%
44,328
11,169
-
15%
3.7
52,130
13%
957
0.09
8,902
-2,171
-6,309
6,731
-893
-4,116
63%
1.88%